A recent survey on primary care spending showed the U.S. lagging behind.
The Commonwealth Fund published an issue brief last week summarizing the results of its two international surveys comparing primary care in the U.S. to nine other developed countries (Canada, New Zealand, Australia and six European countries). The surveys — one of primary care physicians and the other of adults — showed the U.S. lagging behind the other countries in almost every area when it comes to primary care. Adults in the U.S. (and Canada) were the least likely to report having a regular doctor. In the U.S., 43% of adults reported having had the same primary care physician for at least five years compared with 68% in Germany and 76% in the Netherlands. The U.S. also had the lowest percentage (29%) of primary care physicians who occasionally or frequently make house calls.
The relative lack of investment in primary care has been a feature of U.S. healthcare for many years. The Commonwealth Fund brief issue notes that the U.S. spent 4.7% of its total healthcare spending on primary care in 2021 compared with an average of 14% in other high-income countries. Some states have started to steer more money into primary care; the Commonwealth Fund says updating the Medicare physician fee schedule could be an opportunity for “supportive federal policy action” and suggests policymakers consider increasing the compensation for primary care physicians.
Should the U.S. double the amount it spends on primary care?
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
FDA Clears Phase 2 Trial of Cannabis in PTSD
November 20th 2024After a three-year negotiation, the FDA has dropped its objection to allowing patients to self-titrate dosing of smoked cannabis. But regulators want to see additional information about the device that will be used for inhalation.
Read More